Researchers: Priyamadhaba Behera ¹, Binod Kumar Patro ¹, Arvind Kumar Singh ¹, Pradnya Dilip Chandanshive ¹, Ravikumar S R ¹, Somen Kumar Pradhan ¹, Siva Santosh Kumar Pentapati ¹, Gitanjali Batmanabane ², Prasanta Raghab Mohapatra ³, Biswa Mohan Padhy ⁴, Shakti Kumar Bal ³, Sudipta Ranjan Singh ⁵, Rashmi Ranjan Mohanty ⁶

Background: Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in SARS-CoV-2 infection. The study was aimed to explore the association between ivermectin prophylaxis and the development of SARS-CoV-2 infection among healthcare workers.

Conclusion: Two-dose ivermectin prophylaxis at a dose of 300 μg/kg with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Chemoprophylaxis has relevance in the containment of pandemic.

[National Institutes of Health]

Published: 05th November 2020 12:55 AM  |   Last Updated: 05th November 2020 12:55 AM

BHUBANESWAR: In a significant finding, two-dose Ivermectin prophylaxis has led to 73 per cent
reduction in COVID-19 infection among healthcare workers (HCWs), who are more likely to contract the virus given their nature of job.

“Earlier, at least 20 to 25 HCWs were getting infected with the virus daily. After the workers started taking Ivermectin, the number of infection has come down to one or two per day,” Dr Batmanabane said.

“Considering the fact that Ivermectin had been shown to have diverse mechanisms by which it successfully attacks the SARS-CoV-2, we decided to use it. The Ivermectin has a proven safety profile as a safe drug which has been used for many decades. The encouraging results of a study from Egypt prompted us to explore its role as prophylaxis for HCWs,” she said. . . .

[New India Express]

Following an intense daylong public discussion, a panel of scientific advisors to the U.S. Food and Drug Administration (FDA) today voted 16 to 2 against recommending a third shot of Pfizer’s COVID vaccine for people 16 and older.

The Biden administration has been hoping the FDA would approve a third shot of the Pfizer vaccine in time to begin rolling out boosters for Pfizer recipients next week, the New York Times reported.

The vote came after a sharp debate in which many of the panel’s independent experts, including infectious disease doctors and statisticians, challenged whether the data justified a broad rollout of extra shots when the vaccines appear to still offer robust protection against severe COVID-19 disease and hospitalization, at least in the U.S.

“It’s unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease,” said Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health.

The issue of whether or not to approve boosters has become increasingly contentious, dividing scientists, both outside and inside the FDA, including two scientists who recently announced they are leaving the agency because of pressure from the Biden administration to approve boosters, citing the lack of data to support a third shot.

“It’s a welcome sight to see actual deliberations in meetings about vaccine booster shots at the FDA,” said Mary Holland, president of Children’s Health Defense. “It’s encouraging that a panel of experts stood up to political and corporate pressure based on the lack of convincing data for safety and efficacy of boosters.”

Holland added:

“One can only hope the FDA and Centers for Disease Control and Prevention panels will continue to engage in vigorous debate about vaccine science and medicine.”

As The Hill reported, the advisory panel’s vote is not binding, so the FDA doesn’t have to accept the results. But if the agency doesn’t, it will raise significant questions of political interference and pit agency scientists against political officials who signed off on the booster plan.

In an unusual move last month, Biden and top health officials, including Surgeon General Vicek Murthy, acting FDA Commissioner Dr. Janet Woodcock and CDC  Director Dr, Rochelle Walensky, publicly announced a booster shot program would begin the week of Sept. 20, well before the FDA and CDC examined the evidence.

On Thursday, FDA scientists had expressed skepticism about the need for Pfizer COVID vaccine booster shots in a report released Wednesday.

In 23-page report, FDA officials said, based on their analysis of data submitted by Pfizer and BioNTech, they could not yet take a stance on whether to recommend COVID boosters for the general public.

SIGN UP #TheDefender: https://t.co/zL66Edfiw5https://t.co/dvbbGv87R2

— Robert F. Kennedy Jr (@RobertKennedyJr) September 16, 2021

The 23-page report analyzed data submitted by Pfizer and BioNTech as part of the drugmakers’ request for authorization for their vaccine to be given as a booster shot in people 16 years and older.

[Children’s Health Defense]

As of September 2021, the standard protocol for Covid-19 patients is still to be sent home and when their lips turn blue from low oxygen, they are hospitalized. Knowing they’re at risk of being hospitalized Americans are desperately seeking for some sort of treatment.

Dr. Malone discusses the bizarre amount of misinformation that is being spread about perfectly safe and useful medications, such as the Nobel Prize winning drug for human use, Ivermectin.

What ever happened to the Liberal cry that government should not come between a patient and her doctor?

Sweden became the second European Union country to ban Israeli residents from entry due to a rise in COVID-19 cases in Israel, despite the country being one of the most vaccinated countries in the world.

Portugal on Wednesday became the first EU country to ban travel from Israel due to a rise in cases. Both countries are following the EU’s recommendation to remove Israel from its list of green countries.

Sweden also banned the entry of citizens from the United States, Kosovo, Lebanon, Montenegro, and North Macedonia.

Interior Minister Mikael Damberg told news outlets that the sharp increases in COVID-19 cases in Israel, the United States, and other countries are the reason why they were removed from Sweden’s travel ban exemption. Despite Israel’s mass vaccination campaign, the virus has continued to spread, Damberg said.

According to a news release from the Swedish government, it will reintroduce a travel ban on Israel, the U.S., and other countries starting from Sept. 6.

“Regarding foreign citizens travelling to Sweden from the US, Israel, Kosovo, Lebanon, Montenegro, and North Macedonia as of 6 September, only those covered by another exemption from the entry ban may enter Sweden,” said the release. “This could concern foreign citizens who have residence permits in Sweden, have particularly urgent needs or are to carry out essential functions, and who can also present a negative COVID-19 test. The negative COVID-19 test result may not be older than 48 hours. This requirement applies to foreign citizens aged 18 and older, with certain exemptions.”

The Swedish government said it is following the EU’s guidelines on removing those countries from its safe travel list, and it said the directive will be revisited at a later date.

Several Israeli politicians criticized the EU’s directive and Portugal’s mandate. . . .

[The Epoch Times]

Breakthrough cases reach majority levels in some jurisdictions but numbers elude CDC.

“I’m not going to arm wrestle with the administration about where to put you,” Dr. C., a highly skilled gastroenterologist, said gently to my friend who was in bed in a triage room in the ER. “We just want to get you into a bed so we can figure out what’s wrong and get you treated.”

We were at our small town’s hospital. No one was sure why, but my friend had not been able to keep anything more than a handful of raspberries down since a complicated surgery for a chronic health condition three weeks before. Dehydrated and unable to eat, my friend had been violently vomiting after taking just a sip of water or sucking on an ice chip, and had lost nearly twenty-five pounds.

I was by my husband’s side when he had a gallbladder attack so severe that it left his hands shaking. I’ve had three unmedicated childbirths and attended many more, both as a journalist and a patient advocate. Still, I’ve never seen a human in so much pain.

Diagnosed with a Pancreas Disorder, Admitted as a COVID Patient

After a battery of testing, my friend was diagnosed with pancreatitis. But it was easier for the hospital bureaucracy to register the admission as a COVID case.

Let me explain. This patient had none of the classic symptoms of COVID: No shortness of breath, no fever, no chills, no congestion, no loss of sense of smell or taste, no neurological issues. The only COVID symptoms my friend had were nausea and fatigue, which could also be explained by the surgery. However, nearly three weeks earlier, a COVID test had come back positive.

The mainstream media is reporting that severe COVID cases are mainly among unvaccinated people. An Associated Press headline from June 29 reads: “Nearly all COVID deaths in US are now among unvaccinated.” Another, from the same date: “Vast majority of ICU patients with COVID-19 are unvaccinated, ABC News survey finds.”

Is that what’s really going on? It’s certainly not the case in Israel, the first country to fully vaccinate a majority of its citizens against the virus. Now it has one of the highest daily infection rates and the majority of people catching the virus (77 percent to 83 percent, depending on age) are already vaccinated, according to data collected by the Israeli government.

After carefully reviewing the available data, including the safety and efficacy profiles of the mRNA vaccines, my friend had taken a cautious approach. Though a medical doctor who gives vaccines in the office every day, my friend opted to wait and see. According to WebMD, a “huge number” of frontline hospital workers have also chosen not to get the vaccine. Indeed, various news reports, from California to New York, confirm that up to 40 percent of health care workers have decided the risks of the vaccines do not outweigh the benefits.

After admission, I spoke to the nurse on the COVID ward. She was suited up in a plastic yellow disposable gown, teal gloves, and two masks underneath a recirculating personal respiratory system that buzzed so loudly she could barely hear. The nurse told me that she had gotten both vaccines but she was feeling worried: “Two thirds of my patients are fully vaccinated,” she said.

[The Epoch Times – Full Article]

Published online 2021 Apr 22.

Title: Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Researchers: Pierre Kory, MD,^1,* Gianfranco Umberto Meduri, MD,² Joseph Varon, MD,³Jose Iglesias, DO,⁴ and Paul E. Marik, MD⁵

Conclusions: Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.

[Full Article At NIH]

So the FDA warns against using Hydroxychloroquine and Zinc, Fauci reluctantly says Vitamin D3 may help and now the FDA and Medical Boards are lined up against Ivermectin. Perhaps it’s because they reduce death and disease without an mRNA ‘vaccine’ as published at the National Institutes of Health.

Published online 2021 Aug 3.

Title: Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19

Researchers: A.D. Santin,¹ D.E. Scheim,^2,∗ P.A. McCullough,³ M. Yagisawa,⁴ and T.J. Borody⁵

Abstract, Partial, Paragraph 1 : “Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments.”

[Full Article, National Institutes of Health]